What is a 'detection window'?
A detection window is the approximate period after use during which a drug or its metabolite remains detectable in a specific specimen. Windows depend on substance, dose, frequency of use, individual physiology, hydration, and lab cutoff — they are not precise predictions of when a test will "pass" or "fail," and they should not be used that way.
What detection windows are (and aren't)
A drug test answers a narrow technical question: is the targeted analyte present above the laboratory's cutoff in this specimen? A detection window answers a related but distinct question: how long after use does that analyte typically remain above the cutoff? These are population-level estimates with significant individual variation. They are useful as a frame for understanding what a result means — they are not a prediction engine.
Treating detection windows as deterministic — "I last used X days ago, so I'll pass" — is the most common way people misread them, and it routinely produces unverified positives and unintended consequences. Always treat a window as a range, not a deadline.
Variables that change windows
- Dose and frequency. A single use clears faster than chronic use, sometimes dramatically (THC is the canonical example).
- Body composition. Fat-soluble metabolites (notably THC-COOH) accumulate more in higher-BMI bodies.
- Hydration and renal function. Affects urine excretion rates and specimen concentration.
- Genetic metabolism variation. CYP enzyme polymorphisms affect clearance of opioids, methadone, benzodiazepines.
- Laboratory cutoff. A 50 ng/mL screening cutoff produces a shorter detection window than a 15 ng/mL one.
- Specimen choice. Hair captures a different window than urine, which captures a different window than oral fluid.
Substance × specimen matrix
Use the interactive explorer below to filter the matrix by substance, specimen, and use pattern.
Detection-window explorer
Select substances and specimens to compare approximate detection windows. Ranges vary by individual physiology, dose, frequency of use, and lab cutoff — they are not predictive of whether someone will "pass" a test.
| Substance | Specimen | Pattern | Window | Caveat |
|---|---|---|---|---|
| THC (cannabis / marijuana) | Urine | Occasional | 1–3 days | Single use; cutoff and hydration affect detection. source |
| THC (cannabis / marijuana) | Urine | Chronic | 10–30 days | Daily, heavy use can extend to ~30 days or longer due to fat-soluble metabolite accumulation. source |
| THC (cannabis / marijuana) | Saliva | Typical | 1–24 hours | Detects recent exposure (smoked/vaped); ingested edibles may shift the window. source |
| THC (cannabis / marijuana) | Blood | Occasional | 1–12 hours | THC redistributes quickly; not a reliable indicator beyond same-day use in non-chronic users. source |
| THC (cannabis / marijuana) | Blood | Chronic | 1–7 days | Residual THC and metabolites can persist longer in chronic, daily users. source |
| THC (cannabis / marijuana) | Hair | Typical | 7–90 days | ~7–10 day incorporation delay; hair is not federally approved under SAMHSA/DOT and has documented bias concerns. source |
| Cocaine | Urine | Occasional | 1–3 days | Benzoylecgonine is the primary urinary marker. source |
| Cocaine | Urine | Chronic | 3–7 days | Heavy use may extend benzoylecgonine excretion. source |
| Cocaine | Saliva | Typical | 1–48 hours | Cocaine itself appears in oral fluid; detection is short. source |
| Cocaine | Blood | Typical | 1–12 hours | Short plasma half-life; benzoylecgonine slightly longer. source |
| Cocaine | Hair | Typical | 7–90 days | ~7–10 day incorporation delay; reflects historical not recent use. source |
| Opioids (opiates) | Urine | Occasional | 1–3 days | Morphine/codeine typically clear within ~3 days. source |
| Opioids (opiates) | Urine | Chronic | 3–7 days | Detection extends with chronic use, particularly with semi-synthetics. source |
| Opioids (opiates) | Saliva | Typical | 1–48 hours | Oral fluid window is short; useful for recent use detection. source |
| Opioids (opiates) | Blood | Typical | 1–24 hours | Plasma half-life is generally short. source |
| Opioids (opiates) | Hair | Typical | 7–90 days | ~7–10 day incorporation delay; hair is not federally approved. source |
| Amphetamines & methamphetamine | Urine | Occasional | 1–3 days | Urinary pH affects excretion of methamphetamine and amphetamine. source |
| Amphetamines & methamphetamine | Urine | Chronic | 3–5 days | Heavy use can extend the window modestly. source |
| Amphetamines & methamphetamine | Saliva | Typical | 1–48 hours | Detects parent compound; window is short. source |
| Amphetamines & methamphetamine | Blood | Typical | 1–48 hours | Plasma half-life varies by isomer. source |
| Amphetamines & methamphetamine | Hair | Typical | 7–90 days | ~7–10 day incorporation delay. source |
Approximate ranges only. Detection depends on individual physiology, dose, frequency of use, hydration, and the laboratory's cutoff and method. Do not use this tool to time or attempt to evade a drug test — that is not what it is for.
THC: a special case
Cannabis (THC) is the substance most likely to confuse window expectations. The urine assay targets THC-COOH, an inactive metabolite that is highly fat-soluble and accumulates in adipose tissue with chronic use. As a result:
- A single, occasional use is typically detectable in urine for 1–3 days.
- Daily, heavy use can extend the window to 30 days or more after cessation.
- Detection of THC-COOH does not indicate active impairment; the metabolite is inactive.
This is why state and municipal cannabis-testing reforms (see cannabis & state law) have increasingly tied employment decisions to impairment evidence rather than test results alone for non-safety-sensitive roles.
How windows vary by specimen
- Saliva (oral fluid) — recent use, hours to ~48h. Detects parent compound; best for post-accident and reasonable-suspicion contexts.
- Urine — days for most analytes; weeks for chronic THC. The workplace default.
- Blood — hours to a day. Best correlation with active concentration; used in medical, forensic, and post-accident contexts.
- Hair — up to ~90 days with a ~7–10 day incorporation delay. Long historical lookback; not federally approved.
- Breath — alcohol only; hours. The federally approved alcohol method.
Detection ≠ impairment
Using detection windows responsibly
The legitimate uses of detection-window information are educational: understanding why a result came back the way it did, why programs are designed the way they are, and why a non-negative result is not a verdict on impairment. The illegitimate uses — timing a test to "pass," coaching evasion, or reasoning about whether a specimen will clear before a test — are not why drugtest.co exists.
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine)
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral Fluid)
- 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs
- Public Policy Statement on Drug Testing in Addiction Treatment
- Final Notice — Addition of Fentanyl and Norfentanyl to Federal Workplace Drug Testing Panels